Company / Free Cash Flow
Solventum Free Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$10.0M
FY2025
5-year range
-$10.0M / $1.6B
FY2022-FY2025
Trend
-101.2%
vs FY2024
Sector context
#122 of 151
Health Care
What the data says
Solventum's free cash flow of -$10M is lower than 81% of companies in the Health Care sector (FY2025). Declined from $1.6B to -$10M over the past 2 years.
Based on SEC 10-K filings.
-$10M in FY2025.
Declined from $1.6B to -$10M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 151This company -$10.0M Sector average $779.8M
▼
-101.3% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 101.2% year-over-year.
- Ranks #122 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.0M | -101.2% |
| FY2024 | $805.0M | -50.5% |
| FY2023 | $1.6B | +13.8% |
| FY2022 | $1.4B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026